Safety and caution characterize the next frontier of Rx-to-OTC switches

Rx-to-OTC Switch Forecasts
Rx-to-OTC Switch Forecasts

Companies are being more selective in the Rx-to-OTC switches they pursue, according to new research just published by Kline & Company in the 13th study in its venerable syndicated series, Rx-to-OTC Switch Forecasts USA: Next Frontier.

Safety is paramount, and the sophistication of clinical studies required to gain approval has increased the cost burden and risk to switch sponsors. Most future switches will depend on a combination of market-driven forces and safety, as determined by regulators. (more…)

OTC contraceptives and personal lubricants propel sales gains for OTC feminine products in 2016

The emergency contraceptives segments of the OTC feminine products market, particularly Teva Pharmaceuticals’ Plan B and store brand copies of Plan B, drove significant gains for the otherwise flat category, according to Kline’s just-published Nonprescription Drugs USA 2016 study. Sales of OTC contraceptive products continue to show strong growth in 2016 as a category, driven entirely by steadily expanding consumer awareness, appeal, and accessibility to the relatively new and expanding range of emergency feminine contraceptive products. (more…)

Nutritional supplements aimed at specific health issues and backed by scientific studies experience gains

Select vitamin brands aimed at eye and brain health had significant sales gains in 2016, according to Kline’s just-published Nonprescription Drugs USA 2016 study. Preservision adult multivitamins for eye health, which is marketed by Valeant Pharmaceuticals, experienced sales growth over 20.0% in 2016, driven by a switch from print to television media for the brand and claims that “only Preservision’s formula has been proven to reduce the risk of progression of moderate to advanced Age-related Macular Degeneration (AMD) in the National Eye Institute’s Age-related Eye Disease Study (AREDS).” Preservision contains high potency antioxidants and minerals, such as 1,000mg omega-3 fatty acids, lutein, and zeaxanthin, and claims to be “the only clinically proven formula.” (more…)

Strong uptake for J&J and GSK brands in the OTC analgesics market

Steady supply and distribution of brands that had previously been recalled continued to experience strong sales gains in 2016, according to Kline’s research for its annual Nonprescription Drugs USA study.

Johnson & Johnson’s Tylenol and Motrin brands, which had been off the market for several years, are making a substantial comeback supported by strong advertising and marketing. GlaxoSmithKline’s Excedrin brands was also temporarily off the market and enjoys steady gains in 2016 as it is in predictable supply with retailers again. All other major OTC pain reliever brands and store brands experience flat to declining sales in 2016 with the exception of Prestige Brands’ BC and Goody’s pain relief powders and Doan’s (Dr. Reddy’s Laboratories). (more…)

Is an ounce of prevention worth more than a pound of OTC treatment for digestive ailments?

One area that shows much higher rates of growth than monograph OTC digestive products are brands that offer claims of improving digestive health and immunity. Probiotics, prebiotics, and digestive enzymes all offer prevention of digestive ailments, including constipation, and improve regularity. Many brands in these market segments are able to achieve high double-digit gains as they are used on a daily basis, and consumers, therefore, make frequent repeat purchases. Kline’s upcoming Digestive Health, Immunity, and Probiotics: U.S. Market Analysis and Opportunities study will contain complete analyses of this market and sales, growth, and market shares of the leading brands and companies. (more…)

After significant gains in recent past, sales of OTC sleeping aids slow, but alternatives show promise

Findings from our upcoming Nonprescription Drugs USA study estimate that sales of OTC sleeping aids post 3.4% growth to reach $244 million at the factory level in 2016.

After seeing significant growth rates ranging from 50.0% to 15.0% per year in the recent past, the market for OTC sleeping aids is still growing, but at a much slower pace. ZzzQuil (Procter & Gamble), Unisom (Sanofi), and private-label sleeping aids posted growth while the rest of the market was flat or declining in 2016. (more…)

Enabling Efficiency: New Value-added Services for the Foodservice Segment

Foodservice settings are challenged to remain efficient
Foodservice settings are challenged to remain efficient

Foodservice distributors and chemical and machinery manufacturers alike can differentiate themselves by offering foodservice end users value-added services ranging from employee training assistance to information on the latest regulations of food safety to technology-enabled efficiency and labor-saving devices. End users in restaurants, hotels, and other foodservice settings are challenged to remain efficient, compliant, and profitable on a regular basis. Distributors or chemical suppliers that offer cleaning chemicals, tools, or machinery to help end users with these issues are seen as valued partners, and loyalty is developed as a result. For example, foodservice distributor Gordon offers a foodservice regulatory compliance program, including online training modules, webinars, and nutrition resources that helps keep their customers coming back to them.  (more…)

Strong Gains for Select Brands and Companies Among U.S. OTC Market Softness in 2016

Nonprescription Drugs USA

The U.S. OTC market posted 2.2% growth overall from 2015 to 2016, according to Kline’s venerable Nonprescription Drugs USA annual market assessment study. However, topical analgesics, nasal allergy medications, herbal products, and contraceptive products posted much higher rates of dollar sales growth. The calendar year of 2016 was marked as being a weak cold and flu season, which put a damper on sales of many OTC upper respiratory brands and market segments. However, in contrast, nasal allergy sprays grew by double digits, driven by growth of newer Rx-to-OTC switch brands, Flonase Allergy Relief (GlaxoSmithKline), and the addition of Rhinocort Allergy Spray by Johnson & Johnson to the market. This rapid uptake of nasal allergy sprays resulted in a small decline in sales of oral allergy medications.  (more…)